Patient Safety and Quality
AMA PRA Category 1 Credits 1.00
CAMPEP Credits: 1.00
MDCB Credits: 1.00
Jacqueline Zoberi, PhD
Washington University School of Medicine in St. Louis
St. Louis, MO
Radiation oncology, nuclear medicine, surgical subspecialities, endocrinology, medical oncology and other specialties all have roles to play in radiopharmaceutical therapy and this collective approach underscores the intricate interplay of various disciplines, ultimately culminating in a treatment modality that offers both precision and potential for improved patient outcomes. The radiation oncologist - often the authorized user - serves a critical role as both the specific disease expert and treatment modality expert. This session presents the findings from ASTROs Radiopharmaceutical Therapy Safety White Paper, describing practical information on establishing and maintaining a radiopharmaceutical program in radiation oncology.
Speaker: Jacqueline Zoberi, PhD – Washington University School of Medicine in St. Louis
Speaker: John Phillips, MD, MPH – Tennessee Oncology, PLLC
Speaker: Jacqueline Zoberi, PhD – Washington University School of Medicine in St. Louis
Speaker: Philipose Mulugeta, MD – University of Pennsylvania
Speaker: Ravi Patel, MD, PhD – University of Pittsburgh School of Medicine
Speaker: Jacqueline Zoberi, PhD – Washington University School of Medicine in St. Louis